TransCode Therapeutics In...

2.00
-0.52 (-20.63%)
At close: Feb 28, 2025, 3:59 PM
1.94
-2.95%
Pre-market: Mar 03, 2025, 04:35 AM EST

TransCode Therapeutics Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -2.1 -8.09 -101.79 -406.93 -1.17K -1.97K
PEG Ratio 0.02 -0.03 -1.11 -2.17 -17.09 n/a
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 23.72 87.72 34.61 -326.95 -806.26 -1.78K
P/FCF Ratio -2.15 -17.92 -127.9 -2.26K -1.76K -2.99K
P/OCF Ratio -2.15 -18.03 -134.09 -2.26K -1.76K -2.99K
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.27 n/a n/a -0.61 -0.84 -0.94
Quick Ratio 1.28 1.57 8.97 2.05 3.25 1.82
Current Ratio 1.28 1.70 8.97 2.05 3.25 1.82
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage -383.66 -1.06 -64.7 -1.84 -2.91 n/a
Return on Equity (ROE) -11.3 -10.84 -0.34 0.80 0.69 0.90
Return on Assets (ROA) -3.59 -4.63 -0.3 -2.59 -3.74 -2.11
Return on Capital (ROIC) -11.56 -5.76 -0.3 -1.12 -3.23 -3.96
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a